And there you have it. No news is good news. The fundamentals are still in place. The rollercoaster of the last few months is based purely on emotion and market manipulation, meanwhile the IIL story just chugs on oblivious to it.
If you believed before, there's no reason to change your tune now. If you always thought this was a long shot, there is likewise still nothing to change your mind in the events of the last few months.
Personally, I think it's a great story and hope for the sake of the patients who have seen real benefit so far that this drug continues to be available to them, and to all sufferers of SPMS. If we make a little coin along the way, so be it.
DYOR, but I'm looking forward to a very exciting year.
Ann: Phase 2B Trial of MIS416 on Schedule to Complete April 2017, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.005(3.45%) |
Mkt cap ! $41.21M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.0¢ | $55.88K | 361.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 94946 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 56159 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |